NYSE

Lemonade, Inc. (LMND)

381 Thanks from members

Lemonade, Inc. (LMND) exhibits mixed market sentiment following strong Q2 2026 revenue growth and accelerating in-force premiums, countered by persistent bottom-line losses, lofty valuations, and divisions among retail and institutional investors.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →